Skip to main content
. Author manuscript; available in PMC: 2011 Jan 20.
Published in final edited form as: Cell Transplant. 2010 Jun 29;19(11):1397–1412. doi: 10.3727/096368910X513955

Figure 4.

Figure 4

(A) Relative expression of pluripotency markers OCT3/4A and NANOG after 15 days of hESC differentiation. Gene expression is normalized to that of undifferentiated hESCs. (B) Relative expression of heart cell markers on day 15 of differentiation. Gene expression was normalized to that of hESCs differentiated in the same medium as monolayers (Control; also shown for β-MHC expression). (C) The beating rate of hESC-derived cells was modulated by IBMX. *p < 0.005, **p < 0.0005 compared to no IBMX treatment.